Login to Your Account

Roche 'Ignyta' fire in M&A targeted therapy takeout

By Brian Orelli
Staff Writer

Friday, December 22, 2017

Roche Holding AG is acquiring San Diego-based Ignyta Inc. for $1.7 billion with an offer of $27 per share in cash, a 74 percent increase over its closing price on Thursday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription